Institutional members access full text with Ovid®

Share this article on:

Pre-ESRD Care and Mortality in Incident ESRD Patients With Multiple Myeloma

Cobb, Jason, MD*; Plantinga, Laura, PhD*; Luthi, Jean-Christophe, MD, PhD; Lynch, Janet, R., PhD; Huff, Edwin, D., PhD§; Mohan, Sumit, MD, MPH; McClellan, William, M., MD*

American Journal of Clinical Oncology: April 2018 - Volume 41 - Issue 4 - p 367–370
doi: 10.1097/COC.0000000000000275
Original Articles: Hematopoietic

Objectives: The relationship between mortality and pre-ESRD (end-stage renal disease) nephrology care in incident ESRD patients with multiple myeloma (MM) as the primary cause of renal failure has not been examined.

Materials and Methods: Among 439,206 incident US hemodialysis patients with MM as the primary cause of ESRD (June 1, 2005 to May 31, 2009) identified using the US Renal Data System, adjusted odds ratios (OR) for reported pre-ESRD nephrology care for ESRD due to MM (n=4561) versus other causes (n=434,645) were calculated. The association of pre-ESRD nephrology care with subsequent mortality in MM-ESRD patients was examined.

Results: MM-ESRD patients were less likely to have any predialysis nephrology care in the year before initiation of dialysis (34.8% vs. 58.5%; OR=0.38; 95% confidence interval [CI], 0.34-0.43) compared with patients with ESRD due to other causes. MM-ESRD patients compared with others were more likely to have catheters on first dialysis (91.8% vs. 75.6%; OR=4.15; 95% CI, 3.54-4.86). Incident MM-ESRD patients receiving predialysis care for ≥6 months had significantly lower 1-year mortality (hazard ratio 0.89; 95% CI, 0.82-0.97 and 0.88; 95% CI, 0.80-0.96, respectively), relative to those without this care. A catheter for dialysis access was associated with a 1.6-fold increase in 1-year mortality in incident MM-ESRD (hazard ratio 1.55; 95% CI, 1.32-1.83).

Conclusions: MM-ESRD patients were less likely to have predialysis nephrology care and more likely to use catheters on first dialysis. However, predialysis care is independently associated with lower mortality in MM-ESRD patients. Predialysis care should be prioritized in MM patients approaching ESRD.

*Medicine, Renal Division, Emory University School of Medicine, Atlanta, GA

Institute of Social and Preventive Medicine (IUMSP), Centre Hospitalier Universitaire Vaudois, University of Lausanne, Switzerland

Mid-Atlantic Renal Coalition, Richmond, VA

§Centers for Medicare & Medicaid Services, Boston, MA

Columbia University Medical Center, New York, NY

The authors declare no conflicts of interest.

Reprints: Jason Cobb, MD, Medicine, Renal Division, Emory University School of Medicine, Emory University Hospital Midtown, 550 Peachtree Street, MOT 7th Floor, Atlanta, GA 30308. E-mail: jcobb2@emory.edu.

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.